基于影像的无创肝病评估用于慢性肝病肝纤维化分期:支持AASLD实践指南的系统综述
为支持美国肝病研究学会(AASLD)无创肝病评估指南,本系统综述汇总了瞬时弹性成像(TE)、剪切波弹性成像和磁共振弹性成像(MRE)通过肝硬度测量(LSM)分期肝纤维化的准确性证据。共纳入240项研究、61,193例患者,结果显示各技术/疾病对F2-4、F3-4、F4的敏感性分别为51%-95%、70%-100%、60%-100%,特异性分别为36%-100%、74%-100%、67%-99%;MRE似乎最准确,基于影像的无创肝病评估在多数比较中优于基于血液的无创肝病评估。
要点
- TE、剪切波弹性成像和MRE的LSM对肝纤维化检测具有可接受至出色的准确性。
- 准确性从F2-4到F3-4递增,F4最高;MRE似乎是最准确的方法。
- 基于影像的无创肝病评估在多数比较中优于基于血液的无创肝病评估,尤其F3-4/F4。
核心结论
- TE、剪切波弹性成像和MRE的LSM在不同肝病病因中对肝纤维化检测显示出可接受至出色的准确性;准确性从F2-4到F3-4递增,F4最高。
- 需要进一步研究以更好地标准化基于影像的无创肝病评估的使用,尤其是在儿童肝病中。
研究设计与样本
- 系统综述,全面检索从起始至2022年4月使用TE、剪切波弹性成像或MRE通过LSM识别显著纤维化(F2-4)、进展性纤维化(F3-4)或肝硬化(F4)的研究,以组织病理学为参考标准,涵盖成人或儿童不同肝病病因。
- 排除单一疾病实体患者少于50例的研究以及混合肝病病因的研究(HCV/HIV合并感染除外)。
- 从9447项研究中纳入240项研究、共61,193例患者。
主要发现
- 在成人中,所有技术/疾病识别F2-4的敏感性范围为51%至95%,F3-4为70%至100%,F4为60%至100%。
- 在成人中,所有技术/疾病识别F2-4的特异性范围为36%至100%,F3-4为74%至100%,F4为67%至99%。
- TE的可用证据量最大;MRE似乎是最准确的方法。
- 基于影像的无创肝病评估在多数比较中优于基于血液的无创肝病评估,尤其在识别F3-4/F4时。
- 在儿童人群中,基于影像的无创肝病评估可能与人中一样准确。
关键数值与推荐
- 成人中TE、剪切波弹性成像或MRE识别F2-4的敏感性为51%至95%,特异性为36%至100%。
- 成人中识别F3-4的敏感性为70%至100%,特异性为74%至100%。
- 成人中识别F4的敏感性为60%至100%,特异性为67%至99%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要进一步研究以更好地标准化基于影像的无创肝病评估的使用,尤其是在儿童肝病中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Transient elastography (TE), shear wave elastography, and/or magnetic resonance elastography (MRE), each providing liver stiffness measurement (LSM), are the most studied imaging-based noninvasive liver disease assessment (NILDA) techniques. To support the American Association for the Study of Liver Diseases guidelines on NILDA, we summarized the evidence on the accuracy of these LSM methods to stage liver fibrosis (F). APPROACH AND RESULTS: A comprehensive search for studies assessing LSM by TE, shear wave elastography, or MRE for the identification of significant fibrosis (F2-4), advanced fibrosis (F3-4), or cirrhosis (F4), using histopathology as the standard of reference by liver disease etiology in adults or children from inception to April 2022 was performed. We excluded studies with <50 patients with a single disease entity and mixed liver disease etiologies (with the exception of HCV/HIV coinfection). Out of 9447 studies, 240 with 61,193 patients were included in this systematic review. In adults, sensitivities for the identification of F2-4 ranged from 51% to 95%, for F3-4 from 70% to 100%, and for F4 from 60% to 100% across all techniques/diseases, whereas specificities ranged from 36% to 100%, 74% to 100%, and 67% to 99%, respectively. The largest body of evidence available was for TE; MRE appeared to be the most accurate method. Imaging-based NILDA outperformed blood-based NILDA in most comparisons, particularly for the identification of F3-4/F4. In the pediatric population, imaging-based NILDA is likely as accurate as in adults. CONCLUSIONS: LSM from TE, shear wave elastography, and MRE shows acceptable to outstanding accuracy for the detection of liver fibrosis across various liver disease etiologies. Accuracy increased from F2-4 to F3-4 and was the highest for F4. Further research is needed to better standardize the use of imaging-based NILDA, particularly in pediatric liver diseases.
引用
- Duarte-Rojo A, Taouli B, Leung DH, et al. Imaging-based noninvasive liver disease assessment for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline. Hepatology. 2024. PMID: 38489521. doi:10.1097/HEP.0000000000000852
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。